James Rolke, Chief Scientific Officer at LA JOLLA PHARMACEUTICAL CO (LJPC), bought 1,000 shares at $22.00 ($22K) on 2018-08-16, disclosed to the SEC on 2018-08-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.